Cure Glaucoma Newsletter
Cure Glaucoma is an initiative to advance glaucoma research leading to improvements in eye care through philanthropic support.
Winter 2006 (PDF)
You will need Adobe Acrobat Reader to view the newsletter.
|
![]() |
Cure Glaucoma Newsletter
Cure Glaucoma is an initiative to advance glaucoma research leading to improvements in eye care through philanthropic support.
Winter 2006 (PDF)
You will need Adobe Acrobat Reader to view the newsletter.
Important News Controversy Swirls Around Lucentis Julia Haller, professor of opthamology at Johns Hopkins explains why controversy swirls around Lucentis, a new drug approved by the FDA for the treatment of macular degeneration. |